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Potent and Selective Stimulation
of Memory-Phenotype CD81 T Cells
In Vivo by IL-15
et al., 1997; Tanchot et al., 1997). This finding has led
to the view that the survival of naive T cells requires a
covert form of stimulation provided by T cell receptor
(TCR) contact with self MHC/peptide complexes, per-
haps aided by joint exposure to certain cytokines (Vella
Xiaohong Zhang, Siquan Sun, Inkyu Hwang,
David F. Tough,* and Jonathan Sprent²
Department of Immunology, IMM4
The Scripps Research Institute
La Jolla, California 92037
et al., 1997). How such signaling maintains cell survival
without inducing entry into cell cycle is still unclear.
Typical naive T cells are mobile cells residing withinSummary
the recirculating lymphocyte pool and display a charac-
teristic surface phenotype, CD45RBhi CD62Lhi CD44lo/intProliferation of memory-phenotype (CD44hi) CD81 cells
in mice (Swain et al., 1991; Sprent, 1993). Whereas ininduced by infectious agents can be mimicked by in-
young mice naive T cells are a predominant population,jection of type I interferon (IFN I) and by IFN I±inducing
older mice contain substantial numbers of T cells with anagents such as lipopolysaccharide and Poly I:C; such
activated/memory CD45RBlo CD62Llo CD44hi phenotype.proliferation does not affect naive T cells and appears
Memory-phenotype T cells are thought to represent theto be TCR independent. Since IFN I inhibits prolifera-
long-lived progeny of naive T cells responding tovarioustion in vitro, IFN I±induced proliferation of CD81 cells
environmental antigens. Although some memory-phe-in vivo presumably occurs indirectly through produc-
notype T cells remain in interphase for prolonged peri-tion of secondary cytokines, e.g., interleukin-2 (IL-2)
ods, most memory-phenotype cells show a rapid turn-or IL-15. We show here that, unlike IL-2, IL-15 closely
over, suggesting that these cells are subject to constantmimics the effects of IFN I in causing strong and selec-
stimulation (Tough and Sprent, 1994; Tough et al., 1996).tive stimulation of memory-phenotype CD44hi CD81
Which particular stimuli are responsible for the rapid(but not CD41) cells in vivo; similar specificity applies
turnover of memory-phenotype T cells has yet to beto purified T cells in vitro and correlates with much
resolved. The simplest idea is that these cells are main-higher expression of IL-2Rb on CD81 cells than on
tained in a chronic state of activation through contactCD41 cells.
with residual depots of specific antigen and/or by expo-
sure to cross-reactive environmental antigens (Sprent,
Introduction 1993). Another possibility is that memory-phenotype
cells are subject to non±antigen-specific (ªbystanderº)
The factors controlling the life span and turnover (rate stimulation through contact with various cytokines re-
leased during infection with pathogens. In support ofof proliferation) of mature postthymic T cells has long
this idea, injection of mice with type I interferon (IFN I)been controversial (reviewed by Everett and Tyler, 1967;
or Poly I:C, a powerful inducer of IFN I, induces selectiveSprent, 1993). Based on the effects of adult thymectomy
proliferation of memory-phenotype CD44hi CD81 cells(ATx) and adoptive transfer experiments, T cells at a
(Tough et al., 1996); stimulation of these cells appearspopulation level appear to have an indefinite life span.
to be TCR independent because equivalent prolifera-However, the longevity of individual subsets of T cells
tion occurs when b2-microglobulin±negative CD81 cellsis less clear. For rodents, some workers argue that typi-
(raised in chimeras) are exposed toPoly I:C after transfercal T cells with a naive phenotype represent short-lived
to b2-microglobulin±negative mice. Since viral infectionscells which disappear rapidly after removal of the thy-
lead to marked IFN I production, part of the intensemus (Kappler et al., 1974; Rocha et al., 1983; Swain
proliferation of CD44hi CD81 cells seen during the pri-et al., 1991; reviewed by Freitas and Rocha, 1993). By
mary immune response to viruses could represent acontrast, other workers regard naive T cells as poten-
bystander reaction elicited by IFN I. Selective stimula-tially long-lived cells that require the thymus for their
tion of CD44hi CD81 cells in vivo is also found followinginitial production in young life but then become largely
injection of lipopolysaccharide (LPS), another strong in-thymus independent when the thymus atrophies after
ducer of IFN I, or after injection of killed bacteria (Toughpuberty (Miller and Mitchell, 1969; Arthur and Mason,
et al., 1997; D. F. T. and J. S., unpublished data). Signifi-1986; Sprent et al., 1991; von Boehmer and Hafen, 1993).
cantly, LPS-induced T cell stimulation in vivo is low inDespite this controversy on life span, there is general
IFN I receptor±negative (IFN IR2/2) mice, implying anagreement that naive T cells are quiescent cells that
important role for IFN I.rarely enter the cell cycle unless confronted with a spe-
Despite the capacity of IFN I and various microorgan-cific antigen. Nevertheless, naive T cells tend to disap-
isms to cause bystander T cell proliferation in vivo, IFNpear rapidly when deprived of contact with autologous
I is strongly inhibitory for T cell responses in vitro (Petri-major histocompatibility complex (MHC) molecules, MHC
coin et al., 1997). In light of this finding, IFN I may induceI for CD81 cells and MHC II for CD41 cells (Benoist and
T cell proliferation in vivo by causing the release of otherMathis, 1997; Brocker, 1997; Kirberg et al., 1997; Rooke
cytokines that then act directly on T cells. In support
of this idea, evidence is presented that IFN I induces*Present address: The Edward Jenner Institute for Vaccine Re-
interleukin-15 (IL-15) synthesis by antigen-presentingsearch, Compton, Newbury, Berkshire RG20 7NN, England.
cells and that IL-15 causes selective stimulation of puri-²To whom correspondence should be addressed (e-mail: jsprent@
scripps.edu). fied CD44hi CD81 cells in vitro. Moreover, IL-15 mimics
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cells; for these cells, IL-2Ra was slightly higher on CD41
than CD81 cells.
In marked contrast to IL-2Ra and g, the expression
of IL-2Rb was substantially higher on CD81 cells than
CD41 cells, both for naive-phenotype cells and for mem-
ory-phenotype cells (Figure 1). Thus, for naive-pheno-
type CD44lo and CD44int cells, IL-2Rb expression was
undetectable on CD41 cells but readily apparent at a
moderate level on CD81 cells. For memory-phenotype
CD44hi cells, CD41 cells displayed the same modest
level of IL-2Rb expression as naive-phenotype CD44lo
and CD44int CD81 cells. For CD44hi CD81 cells, by con-
trast, IL-2Rb expression on most of these cells was
about 10-fold higher than on CD44hi CD41 cells. Thus, of
IL-2Ra, b, and g expression, only IL-2Rb was selectively
expressed at a high level on CD44hi CD81 cells, i.e., the
target cells for proliferation induced by viruses, Poly I:C
and LPS.
Currently, only two cytokines, IL-2 and IL-15, are
known to bind to T cells via IL-2Rb (Grabstein et al.,
1994; Kennedy and Park, 1996; Bamford et al., 1997).
These two cytokines were thus potential candidates for
mediating the proliferation of CD44hi CD81 cells induced
by injection of the above agents. IL-15 merited particular
consideration because, at least at the level of mRNA,
this cytokine can be synthesized by a wide variety of
cell types (Grabstein et al., 1994; Kennedy and Park,
1996). Moreover, IL-15 synthesis can be elicited by LPS
(Doherty et al., 1996), i.e., by one of the agents causing
proliferation of CD44hi CD81 cells in vivo. The experi-
ments discussed below were designed to address three
questions. First, do the other agents listed above elicit
Figure 1. Expression of IL-2 Receptor Subunits on T Cell Subsets IL-15 synthesis? Second, do IL-2 and IL-15 both share
Using three-color staining, pooled LN cells from normal mice were the capacity to stimulate T cells under in vivo condi-
stained with mAbs specific for IL-2Ra, IL-2Rb, or IL-2Rg followed tions? Third, if so, do both cytokines act selectively on
by mAbs specific for CD4, CD8, and CD44. Gated CD41 or CD81 CD44hi CD81 cells?
cells were analyzed for IL-2Ra, b, or g chain expression on CD44hi,
CD44int, or CD44lo subpopulations.
Requirements for Stimulating IL-15 Synthesis
by Macrophagesthe capacity of IFN I to cause marked proliferation of
IL-15 is difficult to detect at the protein level, but likeCD44hi CD81 cells in vivo. Hence, at least in part, the
LPS, several infectious agents, including mycobacteria,strong bystander stimulation of CD81 cells in vivo elic-
toxoplasma, and viruses, induce monocytes and macro-ited by various infectious agents may be driven by IFN
phages to synthesize IL-15 mRNA (Doherty et al., 1996;I±induced production of IL-15.
Atedzoe et al., 1997). As shown in Figure 2, culturing
thioglycollate-induced peritoneal exudate macrophagesResults
for 4 hr in vitro in the presence of LPS, IFNa, IFNb, or
Poly I:C led to strong synthesis of IL-15 mRNA. IL-15The observation that viruses, Poly I:C, and LPS all cause
synthesis was much lower with IFNg and undetectableselective stimulation of CD44hi CD81 cells in vivo sug-
with IL-12 and IL-15. Thus, except for viruses that weregests that these diverse agents elicit the production of
not tested, all of the agents inducing proliferation ofa common mediator, e.g., a cytokine. If so, CD44hi CD81
CD44hi CD81 cells in vivo induced strong production ofcells would be expected to display a unique pattern of
IL-15 by macrophages, at least at the mRNA level.cytokine receptors. To explore this issue, we arbitrarily
stained subsets of T cells for expression of IL-2 receptor
a (IL-2Ra), b, and g. Examining CD41 and CD81 cells Stimulation of T Cell Subsets by IL-15 In Vitro
To compare the capacity of IL-2 and IL-15 to stimulateexpressing high (hi), intermediate (int), or low (lo) levels
of CD44 showed that all subsets of T cells expressed T cell subsets in vitro, purified populations of lymph
node (LN) CD41 and CD81 cells were cultured in vitro forIL-2Rg at near-equivalent levels, although for CD41 cells
IL-2Rg expression was higher on memory-phenotype 3 days with recombinant IL-2 (mouse) or IL-15 (human) in
the presence of the DNA precursor bromodeoxyuridineCD44hi cells than on naive-phenotype CD44lo and CD44int
cells (Figure 1). Expression of IL-2Ra was low or unde- (BrdU); IFN I (IFNa and IFNb), IFNg, and IL-12 were used
as controls.tectable on naive-phenotype CD44lo and CD44int cellsbut
was clearly detectable on memory-phenotype CD44hi As shown in Figure 3A, a low concentration of IL-15
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including CD44hi/IL-2Rbhi cells (although there was mod-
est stimulation of the minor subset of mixed-phenotype
CD44hi/IL-2Rbint cells) (Figures 3Ba±3Bd). IL-2 was mildly
stimulatory for memory-phenotype CD41 cells, though
only for IL-2Rbint cells (Figures3Be±3Bh); thus, IL-2 stim-
ulated CD44hi/IL-2Rbint cells but not CD44hi/IL-2Rblo cells
(Figures 3Bg and 3Bh). As discussed earlier (Figure 1),
only a minor proportion of CD44hi CD41 cells are IL-
2Rblo. Stimulation of naive-phenotype CD44lo cells by
IL-2 was minimal.
The above data indicated that only IL-15 and not IL-2
caused selective stimulation of CD44hi CD81 cells in
vitro. Thus, IL-15 seemed a likely effector cytokine forFigure 2. IL-15 mRNA Expression in Macrophages
IFN I±induced stimulation of CD44hi CD81 cells in vivo.Doses of 1 3 106 thioglycollate-elicited peritoneal macrophages
from B6 mice were cultured in vitro in medium alone or with IFNa
(1000 U/ml), IFNb (5000 U/ml), IFNg (1000 U/ml), Poly I:C (100 mg/ Background Turnover Rates of CD44hi versusml), LPS (10 mg/ml), IL-12 (500 ng/ml), or IL-15 (100 ng/ml) for 4
IL-2Rbhi CD81 Cells In Vivohr. Total RNA was extracted and reverse transcriptase PCR was
Prior to examining the effects of IL-15 in vivo, it wasperformed to amplify the mRNA levels of mouse IL-15 (365 bp) and
G3PDH (496 bp). PCR products werevisualized by ethidium bromide important to establish the normal turnover of T cell sub-
staining after electrophoresis on an agarose gel. sets expressing different levels of IL-2Rb. To avoid the
production of newly formed T cells in the thymus, ATx
(0.1 mg/ml) was nonstimulatory for CD41 cells, including mice were used. In previous studies, giving normal ATx
CD44hi cells, but caused strong stimulation of CD44hi mice BrdU water led to rapid labeling of memory-pheno-
CD81 cells in vitro (measured at 72 hr); stimulation of type CD44hi cells but very slow labeling of naive-pheno-
CD44lo/int CD81 cells was not seen. By contrast, a 10-fold type CD44lo/int cells, both for CD41 and CD81 cells (Tough
higher concentration of IL-2 (1 mg/ml) caused modest and Sprent, 1994). Data on the turnover of LN T cells
stimulation of CD44hi CD41 cells but failed to stimulate expressing different levels of IL-2Rb are shown in Figure
CD44hi CD81 cells. None of the other cytokines tested 4. The data refer to mice given BrdU continuously for
caused proliferation (relative to the ªbackgroundº prolif- up to 30 days; fluorescence-activated cell sorter (FACS)
eration seen for cells cultured in medium alone). Indeed, data for cells stained after 1 or 30 days on BrdU water
in confirmation of the work of others (Petricoin et al., are shown at the bottom.
1997), IFN I inhibited proliferation, which contrasted with For CD81 cells (Figure 4A), it can be seen that the
the strong proliferation of CD44hi CD81 cells seen after rapid turnover of memory-phenotype CD44hi cells (left)
IFN I injection in vivo (Tough et al., 1996). also applied to IL-2Rbhi cells (middle); likewise, the slow
The capacity of graded concentrations of IL-15 and turnover of naive-phenotype CD44lo/int cells also applied
IL-2 to stimulate various subsets of T cells, including to IL-2Rbint cells. Similarly, for CD41 cells (Figure 4B),
IL-2Rb subsets, is shown in Figure 3B; because of the CD44hi and IL-2Rbint cells displayed a rapid turnover,
much higher concentration of IL-2Rb on CD81 than whereas CD44lo/int and IL-2Rblo cells had a slow turnover.
CD41 cells, CD81 cells were arbitrarily subdivided into The main conclusion from the above data is that, for
IL-2Rbhi vs. int cells, whereas CD41 cells were subdivided CD81 cells, the IL-2Rbhi subset had the same high back-
into IL-2Rbint vs. lo cells. The data make several points, as ground rate of turnover as typical memory-phenotype
follows. CD44hi cells. This finding is to be expected since the
For CD81 cells, even small concentrations of IL-15 majority (50%±80%) of CD44hi CD81 cells are IL-2Rbhi
(0.2 mg/ml) caused strong proliferation of memory-phe- (Figure 1). Interestingly, the minority population of mixed-
notype CD44hi and IL-2Rbhi CD81 cells (Figures 3Ba and phenotype CD44hi/IL-2Rbint cells (Figure 4A, right) also
3Bb) and an increase in the yield of total viable CD81 showed a high rate of turnover, especially during the
cells (Figure 3C); similar findings applied to CD44hi/IL- first 10 days during receipt of BrdU water.
2Rbhi cells (Figure 3Bc). With higher concentrations of IL-
15 (1 mg/ml), BrdU labeling of these memory-phenotype
T Cell Turnover In Vivo after IL-15 Injectionsubsets reached about 50% by 24 hr and was greater
To examine the effects of IL-15 in vivo, mice were giventhan 95% by 42 hr (Figures 3Bc and 3Bd). By contrast,
a single injection of IL-15, or Poly I:C as a control, andIL-15 failed to stimulate naive-phenotype CD81 cells,
then immediately were given BrdU water for 3 days. Ati.e., CD44lo/int cells and IL-2Rbint cells (Figures 3Ba and
this time point, BrdU labeling of CD44hi LN subsets in3Bb). The only exception here was that IL-15 did cause
uninjected mice was about 20% for CD81 cells and 35%moderately strong stimulation of CD81 cells with a
for CD41 cells (Figure 5). Confirming previous resultsªmixedº CD44hi/IL-2Rbint phenotype (Figures 3Bc and
(Tough et al., 1996), injecting mice with Poly I:C, an3Bd); as mentioned earlier (Figure 1), only a small pro-
inducer of IFN I, markedly increased BrdU labeling ofportion of CD44hi cells have an IL-2Rbint phenotype. For
CD44hi CD81 cells but had little or no effect on CD44hiCD41 cells, even high concentrations of IL-15 caused
CD41 cells (Figure 5A, top; see Figure 5B for summary).little or no stimulation of either naive- or memory-pheno-
Significantly, essentially identical selective labeling oftype cells (Figures 3Be±3Bh and 3C).
CD44hi CD81 cells but not CD44hi CD41 cells occurredThe results with IL-2 were different. In contrast to IL-
15, IL-2 caused only minimal stimulation of CD81 cells, after injection of IL-15 (a single dose of 2 mg/mouse).
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Figure 3. Effects of Cytokines on T Cell Proliferation In Vitro
Purified populations of CD81 or CD41 cells were cultured in the presence of a fixed (A) or variable (B and C) concentration of the cytokines
shown for various periods in the presence of BrdU (12.5 mg/ml). (A and B) After removal of dead cells by Ficoll gradients, cells were stained
for surface markers and BrdU incorporation and analyzed by FACS. The data show percentage BrdU labeling of subsets of T cells expressing
different levels of CD44 and IL-2Rb. Cells were stained after 72 hr of culture in (A) and for 24 or 42 hr of culture in (B). The data in (A) and (B)
are from different experiments. (C) Purified CD81 or CD41 cells (1.5 3 106/ml) were cultured with the indicated concentration of IL-2 or IL-15
for 72 hr; live cells were enumerated under the phase-contrast microscope and by FACS analysis on the basis of forward versus side scatter.
The data show the fold increase in viable cells relative to the input number (C, top) and percentage of viable cells (C, bottom) at the end of
the culture period.
For CD81 cells, BrdU labeling after either Poly I:C or IL- Kinetics
When mice were injected with IL-15 (2 mg/mouse) and15 injection was restricted to IL-2Rbhi cells (Figures 5A
and 5B, middle), although there was moderate labeling then were given BrdU water continuously for up to 7
days, BrdU incorporation by LN CD81 IL-2Rbhi cellsof the minor subset of mixed-phenotype CD44hi/IL-2Rbint
cells (Figures 5A and 5B, bottom). For CD41 cells, label- reached a maximum on day 3 and then remained at a
plateau until day 7 (Figure 7A, left); similar findings ap-ing of all subsets remained at background levels after
IL-15 injection. plied to CD44hi CD81 cells (data not shown). Stimulation
of naive-phenotype CD81 IL-2Rbint cells by IL-15 wasIn contrast to IL-15, IL-2 injection (40 mg/mouse)
caused only low-level stimulation of T cells (Figure 5B). undetectable at all time points examined (relative to
control mice injected with phosphate-buffered salineThe minimal stimulation induced by IL-2 was restricted
to memory-phenotype cells but affected both CD41 and [PBS]) (Figure 7A, middle). With injection of IL-2 (40 mg/
mouse), BrdU incorporation by IL-2Rbhi and CD44hi CD81CD81 cells.
Injection of titrated doses of cytokines (Figure 6) indi- cells was only slightly higher than in PBS-treated control
mice on days 2±7 postinjection (Figure 7A and data notcated that even small doses of IL-15 (,1 mg) caused
strong stimulation of both CD44hi CD81 and IL-2Rbhi shown); similar findings applied for memory-phenotype
(IL-2Rbint) CD41 cells (Figure 7A). For naive-phenotypeCD81 cells. By contrast, doses of up to 40 mg of IL-2
caused only mild stimulation of memory-phenotype CD41 and CD81 cells, BrdU labeling after IL-2 injection
remained at background levels (data not shown).cells, including both CD41 and CD81 cells; peak stimula-
tion was seen with about 10 mg of IL-2. The above data refer to continuous labeling with BrdU
Selective Stimulation of CD81 Subsets by IL-15
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Figure 4. Normal Turnover of CD41 and CD81 T Cells Expressing Different Levels of CD44 and IL-2Rb
Groups of ATx mice were given BrdU water continuously for various periods. Pooled LN cells from these mice were stained for CD4, CD8,
CD44, and IL-2Rb expression and then for BrdU incorporation. The data show the percentage BrdU labeling of subsets of CD81 (A) and CD41
(B) cells; each point represents the mean value for two mice per group. Dot plots show BrdU labeling of gated CD81, CD81 CD44hi, or CD41
cells on days 1 and 30.
given in the drinking water. When mice received a single range of cytokine receptors on T cell subsets, it is nota-
ble that CD44hi CD81 cells showed much higher IL-2Rbinjection of BrdU followed by FACS analysis of T cells
4 hr later, IL-15 injection caused a transient phase of expression than CD44hi CD41 cells; by contrast, expres-
sion of IL-2Ra and IL-2Rg on these two subsets wasBrdU incorporation by IL-2Rbhi CD81 cells at the end of
day 1 (24±28 hr), both for spleen and LN cells; prolifera- equivalent. The important finding was that of the two
cytokines known to bind to T cells via IL-2Rb, i.e., IL-2tion on days 2±3 was very low. By contrast, the prolifera-
tive response induced by Poly I:C injection occurred 1 and IL-15, only IL-15 caused selective stimulation of
CD44hi CD81 cells, both in vitro and in vivo; stimulationday later, i.e., onday 2 rather than day 1 (see Discussion).
For IL-2, the tempo of the low level of proliferation in- of CD44hi CD41 cells was minimal.
The failure of IL-15 to stimulate memory-phenotypeduced by IL-2 was less discrete than for IL-15 and ex-
tended over several days, both for CD81 cells (Figure CD41 cells is surprising because other workers have
found that antigen-activated CD41 cells are highly sensi-7B) and for CD41 cells (data not shown).
tive to IL-15 (Kennedy and Park, 1996). One explanation
for this difference is that, unlike typical memory-pheno-Discussion
type cells, activated CD41 cells express high levels of
a different receptor involved in IL-15 binding, namelyAs discussed earlier, the capacity of various infectious
IL-15Ra (Giri et al., 1995); this receptor has very highagents (viruses and bacteria) and their products (LPS)
binding affinity for IL-15 but is not thought to be involvedto cause selective stimulation of CD44hi CD81 cells in
in signal transduction. In our hands, IL-15Ra expressionvivo can be mimicked by injection of IFN I or Poly I:C,
on normal T cells, including memory-phenotype T cells,an IFN I±inducing compound. Since adding IFN I to puri-
is virtually undetectable (our unpublished data). How-fied T cells in vitro was inhibitory (Figure 3), the notion
ever, confirming the results of others (Giri et al., 1995),that IFN I induces T cell proliferation in vivo by a direct
we find that IL-15Ra is strongly up-regulated in vitroaction on T cells seems unlikely. A more plausible possi-
following TCR activation, both for CD41 and CD81 cellsbility is that IFN I stimulates other cell types (non-T cells)
(our unpublished data). Hence, for CD41 cells, stimula-to produce secondary cytokines that then act directly
tion of these cells via IL-15 may hinge on up-regulationon T cells. In considering which effector cytokines might
of IL-15Ra following contact with specific antigen. Thebe involved, we reasoned that the receptors for the cyto-
situation for CD81 cells may be different because CD44hikine(s) in question would be expressed at a higher level
CD81 cells from normal mice are strongly sensitive toon CD44hi CD81 cells (the targets for IFN I) than on other
T cell subsets. Although we have yet to study the full IL-15 but show little or no expression of IL-15Ra. For
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Figure 5. BrdU Incorporation by T Cell Sub-
sets from Mice Injected with Poly I:C, IL-15,
or IL-2
B6 mice were given BrdU drinking water con-
tinuously for 3 days after intravenous injec-
tion of PBS (control), IL-2 (40 mg/mouse), or
IL-15 (2 mg/mouse) and intraperitoneal injec-
tion of Poly I:C (100 mg/mouse). Pooled LN
cells were stained for CD4, CD8, CD44, and
IL-2Rb and then for BrdU incorporation,
followed by FACS analysis. (A) BrdU incorpo-
ration by CD41 and CD81 cells expressing
different levels of CD44 (top) andIL-2Rb (mid-
dle) or CD44hi CD41 and CD81 subsets ex-
pressing different levels of IL-2Rb (bottom).
(B) The mean values for percentage BrdU la-
beling from four mice per group, derived from
two different experiments.
these cells, the very high expression of IL-2Rb may com- in vivo may operate largely or partly via production of
IL-15. Consistent with this idea, culturing macrophagespensate for the lack of IL-15Ra. Thus, stimulation via
IL-15 may require the combined actions of IL-15Ra and with IFN I or IFN I±inducing agents (LPS and Poly I:C)
in vitro caused rapid synthesis of IL-15, at least at theIL-2Rb and g for CD41 cells but only IL-2Rb and g for
CD81 cells. mRNA level. In light of this finding, one can envisage
that exposure to IFN I in vivo causes macrophages andIt should be noted that the selective effect of IL-15
on memory-phenotype CD81 cells may not apply to hu- perhaps other cell types to produce IL-15, which is then
directly stimulatory for cells expressing high levels ofman T cells. For IL-2Rb expression, it was reported that,
with the exception of naive-phenotype (CD45RO2) CD41 IL-2Rb, notably CD44hi CD81 cells. In other studies we
have found that IFN I or IL-15 injection also causescells, all subsets of human T cells show near-equivalent
expression of IL-2Rb but at a low level (Kanegane and strong proliferation of natural killer cells (our unpub-
lished data); like CD44hi CD81 cells, natural killer cellsTosato, 1996). Moreover, all IL-2Rb1 subsets, including
naive-phenotype CD81 cells, were induced toproliferate express high levels of IL-2Rb. It should be noted that
LPS and Poly I:C fail to stimulate IL-15 mRNA by macro-by IL-15 in vitro. These observations clearly contrast
with the present finding that, in mice, IL-2Rb expression phages from IFN IR2/2 mice (our unpublished data). This
finding implies that IL-15 production elicited by LPS andis conspicuously high on memory-phenotype (CD44hi)
CD81 cells and that only this subset is susceptible to Poly I:C is induced via prior production of IFN I. At the
effector phase, however, IL-15 is IFN I independent.stimulation via IL-15. This apparent discrepancy may
reflect a species difference or simply the use of different Thus, in contrast to Poly I:C, injecting IFN IR2/2 mice
with IL-15 causes strong proliferation of CD44hi CD81markers (CD45RO vs. CD44) to define T cell subsets.
We favor the second possibility because, in our hands, cells (our unpublished data).
Since IFN I injection may lead to the production ofIL-2Rb expression in mice correlates poorly with CD45RB
expression. Thus, while nearly all IL-2Rbhi cells are multiple cytokines, it would be premature to conclude
that IL-15 is the sole effector cytokine for stimulation ofCD44hi, these cells can be either CD45RBlo or CD45RBhi
(our unpublished data). CD44hi CD81 cells in vivo. Assessing this idea will clearly
hinge on examination of the effects of IFN I in IL-152/2In mice, the striking similarity between the effects of
IFN I and IL-15 injection suggests that T cell proliferation mice. Nevertheless, of the cytokines tested to date (IL-2,
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IL-2 in IFN I±induced T cell stimulation in vivo may be
minimal. It is notable that the intensity of T cell stimula-
tion induced by IL-2 was much less than for IL-15. An
obvious concern here is that, not having access to
mouse IL-15, we had to compare mouse IL-2 with human
IL-15. Hence, the possibility must be considered that
human IL-15 is more potent for mouse T cells than is
mouse IL-15. However, other workers have found that
the reverse is true, at least for certain parameters (Ken-
nedy et al., 1998). Whether this also applies to the sys-
tems used here will await further studies.
It is of interest that the kinetics of T cell proliferation
induced by IFN I versus IL-15 in vivo were distinctly
different. Thus, IL-15 elicited a brief phase of T cell pro-
liferation peaking at about 24 hr postinjection, whereas
proliferation induced by IFN I (Poly I:C) was low on day
1 but high on day 2. The simplest explanation for the
retarded onset of proliferation induced by Poly I:C is
that, at the protein level, production of IL-15 following
Poly I:C injection occurs relatively slowly and is minimal
before 24 hr. This notion rests on the assumption that,
via intermediate production of IFN I (see above), Poly
I:C acts directly on the IL-15±producing cells, e.g., on
Figure 6. A Comparison of the Capacity of IL-2 versus IL-15 to macrophages. However it is also possible that cell±cell
Cause Proliferation of Subsets of T Cells In Vivo communication is involved. Thus, Poly I:C may stimulate
Mice were given BrdU continuously in the drinking water for 3 days certain cells, e.g., fibroblasts or endothelial cells, to pro-
after intravenous injection of various doses of IL-2 or IL-15. Pooled duce IFN I, which in turn may stimulate other cell types,LN cells were stained for surface markers and BrdU incorporation
e.g., macrophages, to synthesize IL-15.followed by FACS analysis as for Figure 5. The data show mean
Despite the similar effects of IFN I and IL-15 in vivo,values from two mice per group.
IFN I may be merely one of several cytokines that can
stimulate IL-15 production. In this respect, we have
IL-4, IL-7, IL-12, tumor necrosis factor, IFNg, IL-12 plus found that, like IFN I, two other cytokines, IFNg and IL-
IFNg, and IL-15), only IL-15 caused selective stimulation 12, cause strong and selective stimulation of CD44hi
of purified CD44hi CD81 cells in vitro. With the exception CD81 cells in vivo (our unpublished data) but not in vitro
of IL-2, the other cytokines tested were either inhibitory (Figure 3). At least for IL-12, this effect applies in IFN
or caused only minimal stimulation. IL-2 did cause low- IR2/2 mice, implying that IFN I production is not essen-
level proliferation of CD44hi T cells, both in vitro and in tial. Likewise, although IFN IR2/2 mice are refractory
vivo, but such stimulation affected CD41 cells as well to small doses of LPS, large doses induce significant
as CD81 cells; in fact, under in vitro conditions, IL-2 stimulation of CD44hi CD81 cells (Tough et al., 1997). At
present, however, it has yet to be proved that IFN I,preferentially stimulated CD41 cells. Hence the role of
Figure 7. Kinetics of T Cell Proliferation In
Vivo after Injection of IL-2, IL-15, or Poly I:C
(A) Mice were injected with PBS(control), IL-2
(40 mg/mouse), or IL-15 (2 mg/mouse) and im-
mediately given BrdU in the drinking water
for the time shown. LN cells were then re-
moved and stained for surface markers and
BrdU incorporation followed by FACS analy-
sis. (B) Mice were injected with IL-2 or IL-15
(as for [A]) or with Poly I:C (100 mg/mouse).
At various times thereafter, the mice received
a single intraperitoneal injection of BrdU (1
mg/mouse) followed 4 hr later by staining for
surface markers and BrdU incorporation. In
(A) and (B), each point represents the mean
data from two mice per group.
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chain-biotin (PharMingen). Biotinylated antibodies were detectedIFNg, IL-12, and perhaps other stimulatory cytokines all
with Red 670-streptavidin (Gibco±BRL, Gaithersburg, MD). Stainingact via production of IL-15. Testing this idea will require
for BrdU with anti-BrdU-fluorescein isothiocyanate (Becton Dickin-studies with IL-152/2 mice.
son, Mountain View, CA) was performed as described (Tough and
The susceptibility of CD44hi CD81 cells to stimulation Sprent, 1994). Stained cells were analyzed on a FACSort flow cyto-
by IL-15 could explain the high turnover of these cells meter (Becton Dickinson).
in normal animals. Thus, via low-level IL-15 production,
IL-15 mRNA Expressioncontinuous or intermittent exposure to various infec-
Peritoneal macrophages were collected 3 days after an intraperito-tious agents could maintain memory-phenotype T cells
neal injection of thioglycollate and were stimulated in vitro within a state of chronic activation. For CD81 cells, this idea
different reagents for 4 hr. Total RNA was prepared with an RNeasy
is attractive because memory-phenotype (CD44hi) cells Mini Kit (Qiagen, Santa Clarita, CA); cDNA was synthesized with the
are IL-2Rbhi. However, the situation with memory-type same amount of RNA for each sample. Using a constant amount of
CD41 cells may be different because these cells are cDNA, polymerase chain reactions (PCR) were performed for 30
cycles, with each cycle being 1 min at 948C, 2 min at 548C, and 3largely refractory to the effects of IL-15, perhaps re-
min at 728C. PCR samples were resolved on 1.5% of agarose gels.flecting the much lower expression of IL-2Rb on CD41
PCR for glyceraldehyde 3-phosphate dehydrogenase (G3PDH) wascells than CD81 cells. Yet the turnover of memory-phe-
performed to verify the relative amounts of cDNA used in each
notype T cells in normal animals is as high or higher for amplification reaction. The PCR primers were, for IL-15: (1) CAT
CD41 cells as for CD81 cells (Tough and Sprent, 1994) ATG GAA TCC AAC TGG ATA GAT GTA AGA TA and (2) CAT ATG
(Figure 4). Hence, if the normal rapid turnover of mem- CTC GAG GGA CGT GTT GAT GAA CAT; and for G3PDH (1) TGA
TGG GTG TGA ACC ACG AG and (2) TCA GTG TAG CCC AAG ATGory-phenotype T cells is cytokine driven (which remains
CC. The expected size of the PCR reaction for IL-15 and G3PDH isto be proved), the cytokines acting on CD41 and CD81
365 and 496 bp, respectively.cells are likely to be different.
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